BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26102377)

  • 1. Use of MDCT to Differentiate Autoimmune Pancreatitis From Ductal Adenocarcinoma and Interstitial Pancreatitis.
    Lee-Felker SA; Felker ER; Kadell B; Farrell J; Raman SS; Sayre J; Lu DS
    AJR Am J Roentgenol; 2015 Jul; 205(1):2-9. PubMed ID: 26102377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Pathology? Autoimmune Pancreatitis and Ductal Adenocarcinoma.
    Sureka B; Bansal K
    AJR Am J Roentgenol; 2015 Dec; 205(6):W643. PubMed ID: 26587956
    [No Abstract]   [Full Text] [Related]  

  • 3. Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography.
    Zaheer A; Singh VK; Akshintala VS; Kawamoto S; Tsai SD; Gage KL; Fishman EK
    J Comput Assist Tomogr; 2014; 38(1):146-52. PubMed ID: 24424563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
    Yin Q; Zou X; Zai X; Wu Z; Wu Q; Jiang X; Chen H; Miao F
    Eur J Radiol; 2015 Dec; 84(12):2470-6. PubMed ID: 26481480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory mimickers of pancreatic adenocarcinoma.
    Kothari K; Lopes Vendrami C; Kelahan LC; Shin JS; Mittal P; Miller FH
    Abdom Radiol (NY); 2020 May; 45(5):1387-1396. PubMed ID: 31559473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
    Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
    Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-phase CT of autoimmune pancreatitis: a multireader study.
    Takahashi N; Fletcher JG; Fidler JL; Hough DM; Kawashima A; Chari ST
    AJR Am J Roentgenol; 2008 Feb; 190(2):280-6. PubMed ID: 18212210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma.
    Yoon SB; Jeon TY; Moon SH; Lee SM; Kim MH
    Eur Radiol; 2022 Oct; 32(10):6691-6701. PubMed ID: 35486167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
    Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
    AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT findings in autoimmune pancreatitis: assessment using multiphase contrast-enhanced multisection CT.
    Suzuki K; Itoh S; Nagasaka T; Ogawa H; Ota T; Naganawa S
    Clin Radiol; 2010 Sep; 65(9):735-43. PubMed ID: 20696301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune pancreatitis and non-necrotizing acute pancreatitis: computed tomography pattern.
    Graziani R; Frulloni L; Mantovani W; Ambrosetti MC; Mautone S; Re TJ; Dal Bo C; Manfredi R; Mucelli RP
    Dig Liver Dis; 2012 Sep; 44(9):759-66. PubMed ID: 22546245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging mimics of pancreatic ductal adenocarcinoma.
    Gandhi NS; Feldman MK; Le O; Morris-Stiff G
    Abdom Radiol (NY); 2018 Feb; 43(2):273-284. PubMed ID: 29038855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
    Aslan S; Nural MS; Camlidag I; Danaci M
    Abdom Radiol (NY); 2019 Feb; 44(2):593-603. PubMed ID: 30225610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated Main Pancreatic Duct Dilatation: CT Differentiation Between Benign and Malignant Causes.
    Kim SW; Kim SH; Lee DH; Lee SM; Kim YS; Jang JY; Han JK
    AJR Am J Roentgenol; 2017 Nov; 209(5):1046-1055. PubMed ID: 28858540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune pancreatitis: multidetector-row computed tomography (MDCT) and magnetic resonance (MR) findings in the Italian experience.
    Graziani R; Mautone S; Ambrosetti MC; Manfredi R; Re TJ; Calculli L; Frulloni L; Pozzi Mucelli R
    Radiol Med; 2014 Aug; 119(8):558-71. PubMed ID: 24638911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple solid pancreatic lesions: Prevalence and features of non-malignancies on dynamic enhanced CT.
    Zhu L; Dai MH; Wang ST; Jin ZY; Wang Q; Denecke T; Hamm B; Xue HD
    Eur J Radiol; 2018 Aug; 105():8-14. PubMed ID: 30017302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Vascular Invasion Using a 3-Point Scale Computed Tomography Grading System in Pancreatic Ductal Adenocarcinoma: Correlation With Surgery.
    Zhang L; Zhang ZY; Ni JM; Li B; Chen FM; Jiang CJ; Hu CH
    J Comput Assist Tomogr; 2017; 41(3):394-400. PubMed ID: 27798447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy.
    Sahani DV; Sainani NI; Deshpande V; Shaikh MS; Frinkelberg DL; Fernandez-del Castillo C
    Radiology; 2009 Jan; 250(1):118-29. PubMed ID: 19017924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer.
    Sun GF; Zuo CJ; Shao CW; Wang JH; Zhang J
    World J Gastroenterol; 2013 Jun; 19(23):3634-41. PubMed ID: 23801866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.